News
In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...
Eli Lilly's orforglipron reduced A1C and weight in type 2 diabetes, while weekly insulin efsitora matched daily insulin with fewer side effects.
Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...
The first diabetes and obesity pill that is similar to Ozempic — but in tablet form — may actually outperform the popular injectables drugs.
New diabetes drug may outperform Ozempic jab The first diabetes and obesity pill that works like Ozempic — but in tablet form — may actually outperform the injectables drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results